Interleukin-18 Promoter Polymorphisms in Patients With Behçet’s Disease
- 31 October 2006
- journal article
- Published by Elsevier BV in Human Immunology
- Vol. 67 (10), 812-818
- https://doi.org/10.1016/j.humimm.2006.07.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Serum interleukin-18 levels in patients with Behçet’s disease. Is its expression associated with disease activity or clinical presentations?Rheumatology International, 2005
- Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's diseaseClinical and Experimental Dermatology, 2005
- Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's diseaseClinical and Experimental Immunology, 2004
- Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's diseaseArthritis & Rheumatism, 2004
- Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's diseaseRheumatology, 2004
- T-bet expression is upregulated in active Behcet's diseaseBritish Journal of Ophthalmology, 2003
- Cytokine profile in Behçet's disease patientsScandinavian Journal of Rheumatology, 2002
- Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieuCytokine & Growth Factor Reviews, 2001
- Evidence for linkage of the HLA–B locus in Behçet's disease, obtained using the transmission disequilibrium testArthritis & Rheumatism, 2001
- Th1 polarization of the immune response in Beh et's disease: A putative pathogenetic role of interleukin-12Arthritis & Rheumatism, 1999